{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:43:30Z","timestamp":1792413810299,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Associazione famiglie GNAO"},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ECS 0000024 Rome Technopole"],"award-info":[{"award-number":["ECS 0000024 Rome Technopole"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The heterotrimeric G proteins are ubiquitous membrane-bound complexes specialized in the transduction of receptor-mediated extracellular signals into intracellular responses. Mutations in the G protein subunit alpha O1 (G\u03b1o), encoded by\n                    <jats:italic>GNAO1<\/jats:italic>\n                    , have been associated with neurodevelopmental disorders characterized by prominent movement disorder with or without epilepsy. The\n                    <jats:italic>Gnao1<\/jats:italic>\n                    [C215Y]\/+ mouse model recapitulates key features of the human disease, with a relatively mild phenotype, normal viability and late onset movement abnormalities, detectable in specific motor tasks. Here we report functional alterations in cortical layer V pyramidal neurons from\n                    <jats:italic>Gnao1<\/jats:italic>\n                    [C215Y]\/+ mice, with reduction of the inward currents (Ih) and impairment of the GABAB-mediated outward current. We propose an adeno-associated virus (AAV)-based gene therapy aimed at overexpressing the wild-type form of G\u03b1o by intracerebroventricular injection in newborn heterozygous\n                    <jats:italic>Gnao1<\/jats:italic>\n                    [C215Y]\/ + mice. Our results demonstrate that overexpression of the wild-type protein mitigates behavioral abnormalities and restores functional neuronal deficits in young adult mice, thereby supporting the development of AAV-mediated gene augmentation strategies to counteract the effects of\n                    <jats:italic>GNAO1<\/jats:italic>\n                    variants in patients. The potential of gene supplementation therapy is further supported by data from genetically modified\n                    <jats:italic>C. elegans<\/jats:italic>\n                    strains carrying not only the relatively mild C215Y variant but also a panel of\n                    <jats:italic>goa-1<\/jats:italic>\n                    \/\n                    <jats:italic>GNAO1<\/jats:italic>\n                    mutations associated with more severe phenotypes, suggesting a broader potential of this therapeutic strategy.\n                  <\/jats:p>","DOI":"10.1186\/s40478-026-02389-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:33:02Z","timestamp":1784655182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene supplementation therapy restores motor deficits in Gnao1[C215Y] mice and proves broad efficacy in C. elegans model"],"prefix":"10.1186","volume":"14","author":[{"given":"Germana","family":"Cocozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Maria","family":"Busdraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Chil\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca C.","family":"Follo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Buccheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Folli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Scavizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Raspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir L.","family":"Katanaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Galosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fucile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Limatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2389_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.parkreldis.2018.11.019","volume":"61","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi T, Garone G, Travaglini L, Vasco G, Galosi S, Rios L et al (2019) Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review. Parkinsonism Relat Disord 61:19\u201325 Epub 2018 Nov 16. PMID: 30642806","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2389_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/epi.14653","volume":"60","author":"M Kelly","year":"2019","unstructured":"Kelly M, Park M, Mihalek I, Rochtus A, Gramm M, P\u00e9rez-Palma E et al (2019) Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region. Epilepsia 60(3):406\u2013418. https:\/\/doi.org\/10.1111\/epi.14653. Epub 2019 Jan 25. PMID: 30682224; PMCID: PMC6452443","journal-title":"Epilepsia"},{"issue":"1","key":"2389_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13023-020-01594-3","volume":"15","author":"SY Kim","year":"2020","unstructured":"Kim SY, Shim Y, Ko YJ, Park S, Jang SS, Lim BC et al (2020) Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis. Orphanet J Rare Dis 15(1):343. https:\/\/doi.org\/10.1186\/s13023-020-01594-3. PMID: 33298085; PMCID: PMC7724837","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2389_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/gim.2014.191","volume":"17","author":"X Zhu","year":"2015","unstructured":"Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu YF, McSweeney KM et al (2015) Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med 17(10):774\u2013781. https:\/\/doi.org\/10.1038\/gim.2014.191. Epub 2015 Jan 15. PMID: 25590979; PMCID: PMC4791490","journal-title":"Genet Med"},{"issue":"3","key":"2389_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajhg.2013.07.014","volume":"93","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Kodera H, Akita T, Shiina M, Kato M, Hoshino H et al (2013) De Novo mutations in GNAO1, encoding a G\u03b1o subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet 93(3):496\u2013505 Epub 2013 Aug 29. PMID: 23993195; PMCID: PMC3769919","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2389_CR6","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1212\/NXG.0000000000000143","volume":"3","author":"FR Danti","year":"2017","unstructured":"Danti FR, Galosi S, Romani M, Montomoli M, Carss KJ, Raymond FL et al (2017) GNAO1encephalopathy: broadening the phenotype and evaluating treatment and outcome. Neurol Genet 3(2):e143. https:\/\/doi.org\/10.1212\/NXG.0000000000000143 PMID: 28357411; PMCID: PMC5362187","journal-title":"Neurol Genet"},{"key":"2389_CR7","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.parkreldis.2023.105405","volume":"111","author":"M Novelli","year":"2023","unstructured":"Novelli M, Galosi S, Zorzi G, Martinelli S, Capuano A, Nardecchia F et al (2023) GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments. Parkinsonism Relat Disord 111:105405. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105405. Epub 2023 Apr 29. PMID: 37142469","journal-title":"Parkinsonism Relat Disord"},{"key":"2389_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.04.003","volume":"74","author":"T Wirth","year":"2020","unstructured":"Wirth T, Tranchant C, Drouot N, Keren B, Mignot C, Cif L et al (2020) Increased diagnostic yield in complex dystonia through exome sequencing. Parkinsonism Relat Disord 74:50\u201356. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.04.003. Epub 2020 Apr 20. PMID: 32334381","journal-title":"Parkinsonism Relat Disord"},{"issue":"40","key":"2389_CR9","doi-asserted-by":"publisher","first-page":"eabn9350","DOI":"10.1126\/sciadv.abn9350","volume":"8","author":"YA Larasati","year":"2022","unstructured":"Larasati YA, Savitsky M, Koval A, Solis GP, Valnohova J, Katanaev VL (2022) Restoration of the GTPase activity and cellular interactions of G\u03b1o mutants by Zn2+ in GNAO1 encephalopathy models. Sci Adv 8(40):eabn9350. https:\/\/doi.org\/10.1126\/sciadv.abn9350. Epub 2022 Oct 7. PMID: 36206333; PMCID: PMC9544338","journal-title":"Sci Adv"},{"issue":"5","key":"2389_CR10","doi-asserted-by":"publisher","first-page":"e70196","DOI":"10.1002\/mco2.70196","volume":"6","author":"YA Larasati","year":"2020","unstructured":"Larasati YA, Solis GP, Koval A, Fran\u00e7ois-Heude MC, Piarroux J, Roubertie A et al (2020) Novel mutation at Cys225 in GNAO1-associated developmental and epileptic encephalopathies: clinical, molecular, and pharmacological profiling of case studies. MedComm 6(5):e70196. https:\/\/doi.org\/10.1002\/mco2.70196","journal-title":"MedComm"},{"issue":"6","key":"2389_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/hmg\/ddab296","volume":"31","author":"M Di Rocco","year":"2022","unstructured":"Di Rocco M, Galosi S, Lanza E, Tosato F, Caprini D, Folli V et al (2022) Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia. Hum Mol Genet 31(6):929\u2013941. https:\/\/doi.org\/10.1093\/hmg\/ddab296. PMID: 34622282; PMCID: PMC8947233","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2389_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/genes14020319","volume":"14","author":"M Di Rocco","year":"2023","unstructured":"Di Rocco M, Galosi S, Follo FC, Lanza E, Folli V, Martire A et al (2023) Phenotypic assessment of pathogenic variants in GNAO1 and response to caffeine in C. elegans models of the disease. Genes (Basel) 14(2):319. https:\/\/doi.org\/10.3390\/genes14020319 PMID: 36833246; PMCID: PMC9957173","journal-title":"Genes (Basel)"},{"key":"2389_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2018.05.018","volume":"391","author":"A Koy","year":"2018","unstructured":"Koy A, Cirak S, Gonzalez V, Becker K, Roujeau T, Milesi C et al (2018) Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia. J Neurol Sci 391:31\u201339. https:\/\/doi.org\/10.1016\/j.jns.2018.05.018. Epub 2018 May 22. PMID: 30103967","journal-title":"J Neurol Sci"},{"issue":"2","key":"2389_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jnnp-2017-315653","volume":"89","author":"M Waak","year":"2018","unstructured":"Waak M, Mohammad SS, Coman D, Sinclair K, Copeland L, Silburn P et al (2018) GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS. J Neurol Neurosurg Psychiatry 89(2):221\u2013222. https:\/\/doi.org\/10.1136\/jnnp-2017-315653. Epub 2017 Jul 1. PMID: 28668776","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2389_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40478-022-01312-z","volume":"10","author":"D Silachev","year":"2022","unstructured":"Silachev D, Koval A, Savitsky M, Padmasola G, Quairiaux C, Thorel F et al (2022) Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun 10(1):9. https:\/\/doi.org\/10.1186\/s40478-022-01312-z. PMID: 35090564; PMCID: PMC8796625","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"2389_CR16","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/mds.27771","volume":"34","author":"M Carecchio","year":"2019","unstructured":"Carecchio M, Invernizzi F, Gonz\u00e0lez-Latapi P, Panteghini C, Zorzi G, Romito L et al (2019) Frequency and phenotypic spectrum of KMT2B dystonia in childhood: a single-center cohort study. Mov Disord 34(10):1516\u20131527. https:\/\/doi.org\/10.1002\/mds.27771 Epub 2019 Jun 19. PMID: 31216378","journal-title":"Mov Disord"},{"issue":"6","key":"2389_CR17","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","volume":"33","author":"BJ Byrne","year":"2025","unstructured":"Byrne BJ, Flanigan KM, Matesanz SE, Finkel RS, Waldrop MA, D\u2019Ambrosio ES et al (2025) Current clinical applications of AAV-mediated gene therapy. Mol Ther 33(6):2479\u20132516. https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.045. Epub 2025 May 5. PMID: 40329530; PMCID: PMC12172329","journal-title":"Mol Ther"},{"issue":"4","key":"2389_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41434-025-00532-x","volume":"32","author":"EA Lunev","year":"2025","unstructured":"Lunev EA, Klementieva NV, Vassilieva SG, Volovikov EA, Jappy D, Savchenko IM et al (2025) Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G\u2009>\u2009A linked to encephalopathy. Gene Ther 32(4):430\u2013445. https:\/\/doi.org\/10.1038\/s41434-025-00532-x. Epub 2025 Apr 14. PMID: 40229422","journal-title":"Gene Ther"},{"issue":"4","key":"2389_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/hmg\/ddab235","volume":"31","author":"D Wang","year":"2022","unstructured":"Wang D, Dao M, Muntean BS, Giles AC, Martemyanov KA, Grill B (2022) Genetic modeling of GNAO1 disorder delineates mechanisms of G\u03b1o dysfunction. Hum Mol Genet 31(4):510\u2013522. https:\/\/doi.org\/10.1093\/hmg\/ddab235. PMID: 34508586; PMCID: PMC8863422","journal-title":"Hum Mol Genet"},{"key":"2389_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1895\/wormbook.1.75.2","volume":"2018","author":"MR Koelle","year":"2018","unstructured":"Koelle MR (2018) Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans. WormBook 2018:1\u201352. https:\/\/doi.org\/10.1895\/wormbook.1.75.2. PMID: 26937633; PMCID: PMC5010795","journal-title":"WormBook"},{"issue":"12","key":"2389_CR21","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1016\/j.celrep.2016.11.076","volume":"17","author":"PF Kramer","year":"2016","unstructured":"Kramer PF, Williams JT (2016) Calcium release from stores inhibits GIRK. Cell Rep 17(12):3246\u20133255. https:\/\/doi.org\/10.1016\/j.celrep.2016.11.076","journal-title":"Cell Rep"},{"key":"2389_CR22","doi-asserted-by":"crossref","unstructured":"BRENNER S. 1974 The DNA of Cuenorhabditis elegans. Genetics 77: 95\u2013104","DOI":"10.1093\/genetics\/77.1.95"},{"issue":"12","key":"2389_CR23","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1002\/j.1460-2075.1991.tb04966.x","volume":"10","author":"CC Mello","year":"1991","unstructured":"Mello CC, Kramer JM, Stinchcomb D, Ambros V (1991) Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10(12):3959\u20133970. https:\/\/doi.org\/10.1002\/j.1460-2075.1991.tb04966.x PMID: 1935914; PMCID: PMC453137","journal-title":"EMBO J"},{"key":"2389_CR24","unstructured":"Sulston JE, Hodgkin J (1988) In: Wood WB (ed) The Nematode Caenorhabditis Elegans. Methods. (ed.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 587\u2013606. The Community of C. elegans Researchers"},{"issue":"4","key":"2389_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/nprot.2006.281","volume":"1","author":"TR Mahoney","year":"2006","unstructured":"Mahoney TR, Luo S, Nonet ML (2006) Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc. 1(4):1772-7. https:\/\/doi.org\/10.1038\/nprot.2006.281. PMID: 17487159","journal-title":"Nat Protoc"},{"issue":"2","key":"2389_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/1097-4547(20010115)63:2<196::AID-JNR1011>3.0.CO;2-Y","volume":"63","author":"H Viola","year":"2001","unstructured":"Viola H, Marta CB, Medina JH, Soto EF, Pasquini JM (2001) Anxiolytic-like behavior in rats is induced by the neonatal intracranial injection of apotransferrin. J Neurosci Res 63(2):196\u2013199","journal-title":"J Neurosci Res"},{"issue":"3","key":"2389_CR27","doi-asserted-by":"publisher","first-page":"e0300628","DOI":"10.1371\/journal.pone.0300628","volume":"19","author":"E Lanza","year":"2024","unstructured":"Lanza E, Lucente V, Nicoletti M, Schwartz S, Cavallo IF, Caprini D et al (2024) See Elegans: Simple-to-use, accurate, and automatic 3D detection of neural activity from densely packed neurons. PLoS ONE 19(3):e0300628. https:\/\/doi.org\/10.1371\/journal.pone.0300628. PMID: 38517838; PMCID: PMC10959381","journal-title":"PLoS ONE"},{"issue":"1","key":"2389_CR28","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/s41467-019-09581-4","volume":"10","author":"M Katz","year":"2019","unstructured":"Katz M, Corson F, Keil W, Singhal A, Bae A, Lu Y et al (2019) Glutamate spillover in C. elegans triggers repetitive behavior through presynaptic activation of MGL-2\/mGluR5. Nat Commun 10(1):1882. https:\/\/doi.org\/10.1038\/s41467-019-09581-4. PMID: 31015396; PMCID: PMC6478929","journal-title":"Nat Commun"},{"key":"2389_CR29","doi-asserted-by":"publisher","unstructured":"Strittmatter SM, Valenzuela D, Kennedy TE, Neer EJ, Fishman MC (1990) G0 is a major growth cone protein subject to regulation by GAP-43. Nature. ;344(6269):836\u2009\u2013\u200941. https:\/\/doi.org\/10.1038\/344836a0. PMID: 2158629","DOI":"10.1038\/344836a0"},{"key":"2389_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","volume":"116","author":"H Feng","year":"2018","unstructured":"Feng H, Khalil S, Neubig RR, Sidiropoulos C (2018) A mechanistic review on GNAO1-associated movement disorder. Neurobiol Dis 116:131\u2013141. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.005. Epub 2018 May 24. PMID: 29758257","journal-title":"Neurobiol Dis"},{"key":"2389_CR31","doi-asserted-by":"publisher","unstructured":"Brunori G, Zucca S, Lankford CK, Wang YZ, Franco M, Alekseeva NA et al Conditional modeling of GNAO1 disorder dissociates circuit specific contributions to pathology and rationalizes ameliorative strategies. Mov Disord. 2026 Mar 28. https:\/\/doi.org\/10.1002\/mds.70276. Epub ahead of print. PMID: 41902602","DOI":"10.1002\/mds.70276"},{"issue":"12","key":"2389_CR32","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.1096\/fj.202001113R","volume":"34","author":"S Akamine","year":"2020","unstructured":"Akamine S, Okuzono S, Yamamoto H, Setoyama D, Sagata N, Ohgidani M et al (2020) GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons. FASEB J 34(12):16601\u201316621. https:\/\/doi.org\/10.1096\/fj.202001113R. Epub 2020 Oct 27. PMID: 33107105","journal-title":"FASEB J"},{"issue":"1","key":"2389_CR33","doi-asserted-by":"publisher","first-page":"17097","DOI":"10.1038\/s41598-024-68062-x","volume":"14","author":"R Taira","year":"2024","unstructured":"Taira R, Akamine S, Okuzono S, Fujii F, Hatai E, Yonemoto K et al (2024) Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons. Sci Rep 14(1):17097. https:\/\/doi.org\/10.1038\/s41598-024-68062-x. PMID: 39048611; PMCID: PMC11269603","journal-title":"Sci Rep"},{"key":"2389_CR34","doi-asserted-by":"publisher","first-page":"759574","DOI":"10.3389\/fnbeh.2021.759574","volume":"15","author":"A Eltokhi","year":"2021","unstructured":"Eltokhi A, Kurpiers B, Pitzer C (2021) Baseline depression-like behaviors in wild-type adolescent mice are strain and age but not sex dependent. Front Behav Neurosci 15:759574. https:\/\/doi.org\/10.3389\/fnbeh.2021.759574 PMID: 34690714; PMCID: PMC8529326","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"2389_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cne.11039","volume":"471","author":"T Notomi","year":"2004","unstructured":"Notomi T, Shigemoto R (2004) Immunohistochemical localization of Ih channel subunits, HCN1-4, in the rat brain. J Comp Neurol. 471(3):241\u2009\u2013\u200976. https:\/\/doi.org\/10.1002\/cne.11039. PMID: 14991560","journal-title":"J Comp Neurol"},{"issue":"3","key":"2389_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1152\/physrev.00029.2008","volume":"89","author":"M Biel","year":"2009","unstructured":"Biel M, Wahl-Schott C, Michalakis S, Zong X (2009) Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 89(3):847\u2009\u2013\u200985. https:\/\/doi.org\/10.1152\/physrev.00029.2008. PMID: 19584315","journal-title":"Physiol Rev"},{"issue":"3","key":"2389_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neuron.2012.05.027","volume":"75","author":"CS Kim","year":"2012","unstructured":"Kim CS, Chang PY, Johnston D (2012) Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors. Neuron. 75(3):503\u2009\u2013\u200916. https:\/\/doi.org\/10.1016\/j.neuron.2012.05.027. PMID: 22884333","journal-title":"Neuron"},{"issue":"3","key":"2389_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1152\/physrev.00036.","volume":"84","author":"B Bettler","year":"2004","unstructured":"Bettler B, Kaupmann K, Mosbacher J, Gassmann M (2004) Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev. 84(3):835\u2009\u2013\u200967.https:\/\/doi.org\/10.1152\/physrev.00036.2003. PMID: 15269338","journal-title":"Physiol Rev"},{"issue":"1","key":"2389_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","volume":"26","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Kaupmann K (2005) Don\u2019t worry \u2018B\u2019 happy! a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci 26(1):36\u201343. https:\/\/doi.org\/10.1016\/j.tips.2004.11.004 PMID: 15629203","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2389_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/nat.2023.0043","volume":"34","author":"NV Klementieva","year":"2024","unstructured":"Klementieva NV, Lunev EA, Shmidt AA, Loseva EM, Savchenko IM, Svetlova EA et al (2024) RNA interference effectors selectively silence the pathogenic variant GNAO1c.607 G\u2009>\u2009a in vitro. Nucleic Acid Ther 34(2):90\u201399 https:\/\/doi.org\/10.1089\/nat.2023.0043 Epub 2024 Jan 12. PMID: 38215303","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"2389_CR41","doi-asserted-by":"publisher","first-page":"102432","DOI":"10.1016\/j.omtn.2024.102432","volume":"36","author":"I Shomer","year":"2024","unstructured":"Shomer I, Mor N, Raviv S, Budick-Harmelin N, Matchevich T, Avkin-Nachum S et al (2024) Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder. Mol Ther Nucleic Acids 36(1):102432. https:\/\/doi.org\/10.1016\/j.omtn.2024.102432. PMID: 39897576; PMCID: PMC11787015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"2389_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1124\/jpet.124.002117","volume":"390","author":"AJ Roy","year":"2024","unstructured":"Roy AJ, Leipprandt JR, Patterson JR, Stoll AC, Kemp CJ, Oula ZD et al (2024) AAV9-mediated intrastriatal delivery of GNAO1 reduces hyperlocomotion in Gnao1 heterozygous R209H mutant mice. J Pharmacol Exp Ther 390(2):250\u2013259. https:\/\/doi.org\/10.1124\/jpet.124.002117. PMID: 38866563","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2389_CR43","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","volume":"34","author":"BS Muntean","year":"2021","unstructured":"Muntean BS, Masuho I, Dao M, Sutton LP, Zucca S, Iwamoto H, Patil DN, Wang D, Birnbaumer L, Blakely RD, Grill B, Martemyanov KA (2021) G\u03b1o is a major determinant of cAMP signaling in the pathophysiology of movement disorders. Cell Rep 34(5):108718. https:\/\/doi.org\/10.1016\/j.celrep.2021.108718. PMID: 33535037","journal-title":"Cell Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02389-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:02:38Z","timestamp":1792411358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2389"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02389-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experiments described in the present work were approved by the Italian Ministry of Health (authorization n\u00b0 663\/2023-PR) in accordance with the guidelines on the ethical use of animals from the European Community Council Directive of 22 September 2010 (2010\/63\/EU), and from the Italian D.Lgs 26\/2014.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"217"}}